Clovis Oncology Announces Partial Adjournment of Annual Meeting of StockholdersBusiness Wire • 06/10/21
Clovis (CLVS) Down 5.3% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 06/04/21
Clovis Oncology Highlights Rubraca® (rucaparib) and Lucitanib Data at 2021 ASCO Annual MeetingBusiness Wire • 05/19/21
Clovis Oncology, Inc. (CLVS) CEO Patrick Mahaffy on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/05/21
Clovis Oncology to Present at the Bank of America 2021 Health Care ConferenceBusiness Wire • 04/28/21
Clovis Oncology to Announce First Quarter 2021 Financial Results and Host Webcast Conference Call on May 5Business Wire • 04/21/21
Clovis Oncology Highlights Rubraca® (rucaparib) Clinical Data at AACR Virtual Annual Meeting 2021Business Wire • 04/10/21
Are Options Traders Betting on a Big Move in Clovis Oncology (CLVS) Stock?Zacks Investment Research • 03/22/21